New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
- PMID: 10498889
- DOI: 10.1038/sj.onc.1203035
New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
Abstract
Our analyses in several different tumor settings challenge the prevailing view that malignancies and metastases generally initiate as avascular masses that only belatedly induce vascular support. Instead, we find that malignant cells rapidly co-opt existing host vessels to form an initially well-vascularized tumor mass. Paradoxically, the co-opted vasculature does not undergo angiogenesis to support the growing tumor, but instead regresses (perhaps as part of a normal host defense mechanism) via a process that involves disruption of endothelial cell/smooth muscle cell interactions and endothelial cell apoptosis. This vessel regression in turn results in necrosis within the central part of the tumor. However, robust angiogenesis is initiated at the tumor margin, rescuing the surviving tumor and supporting further growth. The expression patterns of Angiopoietin-2 (the natural antagonist for the angiogenic Tie2 receptor) and vascular endothelial growth factor (VEGF) strongly implicate these factors in the above processes. Angiopoietin-2 is highly induced in co-opted vessels, prior to VEGF induction in the adjacent tumor cells, providing perhaps the earliest marker of tumor vasculature and apparently marking the co-opted vessels for regression. Subsequently, VEGF upregulation coincident with Angiopoietin-2 expression at the tumor periphery is associated with robust angiogenesis. Thus, in tumors, Angiopoietin-2 and VEGF seem to reprise the roles they play during vascular remodeling in normal tissues, acting to regulate the previously underappreciated balance between vascular regression and growth.
Similar articles
-
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.Cancer Res. 2003 Jun 15;63(12):3403-12. Cancer Res. 2003. PMID: 12810677
-
Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.J Clin Invest. 2002 Mar;109(6):777-85. doi: 10.1172/JCI14105. J Clin Invest. 2002. PMID: 11901186 Free PMC article.
-
Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.Cancer Res. 2001 Mar 1;61(5):2145-53. Cancer Res. 2001. PMID: 11280779
-
The clinical implications of angiogenesis in the treatment of cancer.J Med Liban. 2002 Jan-Apr;50(1-2):32-8. J Med Liban. 2002. PMID: 12841311 Review.
-
Lymphatic versus blood vascular endothelial growth factors and receptors in humans.Microsc Res Tech. 2001 Oct 15;55(2):108-21. doi: 10.1002/jemt.1162. Microsc Res Tech. 2001. PMID: 11596156 Review.
Cited by
-
Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents.Int J Mol Sci. 2024 Apr 17;25(8):4433. doi: 10.3390/ijms25084433. Int J Mol Sci. 2024. PMID: 38674018 Free PMC article. Review.
-
Alleviating hypoxia to improve cancer immunotherapy.Oncogene. 2023 Dec;42(49):3591-3604. doi: 10.1038/s41388-023-02869-2. Epub 2023 Oct 26. Oncogene. 2023. PMID: 37884747 Review.
-
Highly concentrated trehalose induces prohealing senescence-like state in fibroblasts via CDKN1A/p21.Commun Biol. 2023 Jan 6;6(1):13. doi: 10.1038/s42003-022-04408-3. Commun Biol. 2023. PMID: 36609486 Free PMC article.
-
Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis.Endocrine. 2023 Apr;80(1):221-230. doi: 10.1007/s12020-022-03257-8. Epub 2022 Dec 12. Endocrine. 2023. PMID: 36509928
-
Adjuvant therapy options in renal cell carcinoma - targeting the metastatic cascade.Nat Rev Urol. 2023 Mar;20(3):179-193. doi: 10.1038/s41585-022-00666-2. Epub 2022 Nov 11. Nat Rev Urol. 2023. PMID: 36369389 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous